DLX4 and gastric cancer: DLX4 has been implicated in shaping an immunosuppressive microenvironment by regulating cell cycle, EMT, glycolysis, and inflammatory pathways, and its high expression correlates with poor survival in GC through the PD-L1/GATA1 axis (31).